The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012

Vaccine

Volumn 32, Issue 29, 2014, Pages 3687-3693

  Turner, Nikki ^a   Pierse, Nevil ^b   Bissielo, Ange ^c   Huang, Q Sue ^c   Baker, Michael G ^b   Widdowson, Marc Alain ^d   Kelly, Heath ^e,f   Bandaranayake, Don ^g   Duque, Jazmin ^g   Grant, Cameron C ^g   Gross, Diane ^g   LeComte, Lyndsay ^g   Mackereth, Graham ^g   McArthur, Colin ^g   Radke, Sarah ^g   Roberts, Sally ^g   Seeds, Ruth ^g   Taylor, Susan ^g   Thomas, Paul ^g   Thompson, Mark ^g   Trenholme, Adrian ^g   Webby, Richard ^g   Williamson, Deborah A ^g   Wong, Conroy ^g   Wood, Tim ^g   more..

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^f VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^g NONE

Author keywords

Immunisation; Influenza vaccine; Vaccination; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; FEVER; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; LABORATORY DIAGNOSIS; NEW ZEALAND; NOSE SMEAR; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; EPIDEMIOLOGY; FEMALE; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEW ZEALAND; SENTINEL SURVEILLANCE; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84901643481     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.013     Document Type: Article

References (31)

1. Nair H., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378(9807):1917-1930.
2. Carrat F., et al. Influenza burden of illness: estimates from a national prospective survey of household contacts in France. Arch Intern Med 2002, 162(16):p1842.
3. World Health Organization WHO vaccine use 2013, World Health Organization, Available from: http://www.who.int/influenza/vaccines/use/en/ [cited 2013 March 28].
4. Manzoli L., et al. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccine Immunother 2012, 8(7):851-862.
5. Jefferson T., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2008, 2(2.).
6. Osterholm M.T., et al. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2011, 12(1):36-44.
7. Hoberman A., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003, 290(12):1608-1616.
8. Shuler C.M., et al. Vaccine effectiveness against medically attended: laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007, 119(3):e587-e595.
9. Baxter R., Lee J., Fireman B. Evidence of bias in studies of influenza vaccine effectiveness in elderly patients. J Infect Dis 2010, 201(2):186-189.
10. Jefferson T., et al. Vaccines for preventing infl{ligature}uenza in the elderly. Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD004876. 10.1002/14651858.CD004876.pub3.
11. Puig-Barbera J., et al. Effectiveness of seasonal 2009-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pnademic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine 2010, 28(47):7460-7467.
12. Eisenberg K.W., et al. Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics 2008, 122(5):911-919.
13. Talbot H., et al. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011, 203(4):500-508.
14. Cheng A.C., et al. Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control. Vaccine 2011, 29:7320-7325.
15. Rondy M., et al. 2011-12 Seasonal influenza vaccines effectiveness against confirmed A (H3N2) influenza hospitalisation: pooled analysis from a European Network of Hospitals. A pilot study. PloS One 2013, 8(4):e59681.
16. Kelly H.A., et al. Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. Influenza and other respiratory viruses 2013, 7(5):729-737.
17. Tricco A.C., et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013, 11(1):153.
18. Foppa I.M., et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
19. Orenstein E.W., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36(3):623-631.
20. World Health Organization Interim epidemiological surveillance standards for influenza 2012, World Health Organization, Available from: http://www.who.int/influenza/resources/documents/influenza_surveillance_manual/en/ [cited 2013 4 September].
21. Jenkinson C., Coulter A., Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ: Br Med J 1993, 306(6890):1437.
22. Shu B., et al. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol 2011, 49(7):2614-2619.
23. Szewczuk E., et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis 2010, 10(1):113.
24. Castilla J.F., et al. Effectiveness of trivalent seasonal and monovalent influenza A (H1N1) 2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/2011 mid-season analysis. Age 2011, 11. (152,585).
25. Castilla J., et al. Influenza vaccine effectiveness in preventing outpatient: inpatient, and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013, 57(2):167-175.
26. Baxter R., Ray G.T., Fireman B.H. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010, 28(45):7267-7272.
27. Kelly H., Steffens I. Complexities in assessing the effectiveness of inactivated influenza vaccines. Euro Surveillance: European Communicable Disease Bulletin 2013, 18.
28. Bragstad K., et al. Low vaccine effectiveness against influenza A (H3N2) virus among elderly people in Denmark in 2012/13-a rapid epidemiological and virological assessment. Euro Surveill 2013, 18(6).
29. Skull S.A., et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007, 25(25):4775-4783.
30. Ohmit S.E., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58(3):319-327.
31. CDC 510(K) Summary for Centers for Disease Control and Prevention Human Influenza Virus Real time RT-PCR Detection and Characterization Panel 2008, CDC.